Slideshow
Author(s):
A new study has found that an RNA-binding protein called TDP-43 could be a promising new biomarker for diagnosing amyotropic lateral sclerosis.
FDA Approves FcRn Blocker Nipocalimab for Broad Forms of Generalized Myasthenia Gravis
Episode 138: Training the Next Generation of Neurology Nurse Practitioners
GLP-1 Agonists and SGLT2 Inhibitors Considered More Effective for Lowering Alzheimer Disease Risk
Episode 137: Advancing Neuromuscular Care and Research
Breaking Down Oculopharyngeal Muscular Dystrophy: From Clinical Gaps to Genetic Gains
Exploring a New Oral Option for Alzheimer Treatment With Sonya Miller